Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies
Journal of Controlled Release · 2023-09 · 361 · 246-259
DOI: 10.1016/j.jconrel.2023.07.044 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Controlled Release, 2023-09. Verfasst von Matthew K Miller und 5 weiteren Autor:innen. Beteiligte Einrichtung: McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and …. Hauptthemen laut MEDLINE: Polymers, Nanoparticles. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Currently, commercially available antibody therapies must be delivered via parenteral administration. Oral delivery of antibodies could increase patient compliance and improve quality of life, however there is currently no viable system for delivering antibodies orally. In this work, a self-assembled, pH-responsive nanoparticle delivery system was developed to load and deliver antibodies via the oral route. The nanoparticles were synthesized via nanoprecipitation using the pH-responsive copolymers based on poly(methacrylic acid-co-methyl methacrylate)-block-poly(ethylene glycol). The reversibly hydrophobic nature of this polymer allowed it to function as an antibody delivery system via self-assembly. Characteristics of the polymer, including monomer ratios and molecular weight, as well as parameters of the nanoprecipitation process were optimized using Design of Experiments to achieve nanoparticles with desired size, polydispersity, loading efficiency, and release characteristics. Ultimately, the synthesized and optimized nanoparticles exhibited a hydrodynamic size within a range that avoids premature clearance, a low polydispersity index, and high IgG loading efficiency. In in vitro antibody release studies at physiologically relevant pH values, the nanoparticles exhibit promising release profiles. The nanoparticles presented in this work show potential as oral delivery vehicles for therapeutic antibodies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- McKetta Department of Chemical Engineering, 200 E. Dean Keeton St. Stop C0400, Austin, TX 78712, USA; Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean K…
- Institute for Biomaterials, Drug Delivery, and Regenerative Medicine, The University of Texas at Austin, 107 W Dean Keeton Street Stop C0800, Austin, TX, USA, 78712; Department of Biomedical Engineering, The University…
Zitieren
APA
Miller, M. K., Chapa-Villarreal, F. A., Oldenkamp, H. F., Elder, M. G., Venkataraman, A. K., & Peppas, N. A. (2023). Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies. Journal of Controlled Release, 361, 246-259. https://doi.org/10.1016/j.jconrel.2023.07.044
Vancouver
Miller MK, Chapa-Villarreal FA, Oldenkamp HF, Elder MG, Venkataraman AK, Peppas NA. Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies. Journal of Controlled Release. 2023;361:246-259. doi:10.1016/j.jconrel.2023.07.044
BibTeX
@article{Miller2023,
author = {Miller, Matthew K and Chapa-Villarreal, Fabiola A and Oldenkamp, Heidi F and Elder, Michael G and Venkataraman, Abhijeet K and Peppas, Nicholas A},
title = {Stimuli-responsive self-assembled polymer nanoparticles for the oral delivery of antibodies},
journal = {Journal of Controlled Release},
year = {2023},
volume = {361},
pages = {246--259},
doi = {10.1016/j.jconrel.2023.07.044}
}
EUVIMED